Journal article · 2021

Abstract 1838: LBL-024, an anti-PD-L1 and 4-1BB bispecific antibody with highly differentiated binding affinity, shows anti-tumor efficacy in a mouse tumor model

Xiao Bo Huang, Jianming Sun, Yurong Qin, Huan Lin, Jing Zhi Guan, Shoupeng Lai, Xiaoqiang Kang, Hong Ling

Cancer Research, 81(13_Supplement), 1838 · Published 1 July 2021 · DOI 10.1158/1538-7445.am2021-1838

View at the publisherCite this paper

In brief

“Abstract 1838: LBL-024, an anti-PD-L1 and 4-1BB bispecific antibody with highly differentiated binding affinity, shows anti-tumor efficacy in a mouse tumor model” is a 2021 journal article by Xiao Bo Huang and 7 co-authors, published in Cancer Research. OpenAlex counts 3 citations as of 18 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
3
Most cited in
2023 (1)
Authors
8

Abstract

Objective: 4-1BB is an inducible costimulatory receptor expressed on activated T and NK cells. 4-1BB ligation on T cells triggers a signaling cascade that results in upregulation of antiapoptotic molecules, cytokine secretion, and enhanced effector function. PD-L1, a ligand of PD-1, is mainly expressed on tumor cells, and a key checkpoint inhibitor implicated in tumor… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Huang, X. B., Sun, J., Qin, Y., Lin, H., Guan, J. Z., Lai, S., Kang, X., & Ling, H. (2021). Abstract 1838: LBL-024, an anti-PD-L1 and 4-1BB bispecific antibody with highly differentiated binding affinity, shows anti-tumor efficacy in a mouse tumor model. Cancer Research, 81(13_Supplement), 1838. https://doi.org/10.1158/1538-7445.am2021-1838

MLA 9

Huang, Xiao Bo, et al. “Abstract 1838: LBL-024, an anti-PD-L1 and 4-1BB bispecific antibody with highly differentiated binding affinity, shows anti-tumor efficacy in a mouse tumor model.” Cancer Research, vol. 81, no. 13_Supplement, 2021, p. 1838. https://doi.org/10.1158/1538-7445.am2021-1838.

Chicago

Huang, Xiao Bo, Jianming Sun, Yurong Qin, Huan Lin, Jing Zhi Guan, Shoupeng Lai, Xiaoqiang Kang, and Hong Ling. 2021. “Abstract 1838: LBL-024, an anti-PD-L1 and 4-1BB bispecific antibody with highly differentiated binding affinity, shows anti-tumor efficacy in a mouse tumor model.” Cancer Research 81 (13_Supplement): 1838. https://doi.org/10.1158/1538-7445.am2021-1838.

Harvard

Huang, X. B. et al. (2021) ‘Abstract 1838: LBL-024, an anti-PD-L1 and 4-1BB bispecific antibody with highly differentiated binding affinity, shows anti-tumor efficacy in a mouse tumor model’, Cancer Research, 81(13_Supplement), p. 1838. doi:10.1158/1538-7445.am2021-1838.

IEEE

X. B. Huang et al., “Abstract 1838: LBL-024, an anti-PD-L1 and 4-1BB bispecific antibody with highly differentiated binding affinity, shows anti-tumor efficacy in a mouse tumor model,” Cancer Research, vol. 81, no. 13_Supplement, p. 1838, 2021, doi: 10.1158/1538-7445.am2021-1838.

BibTeX

@article{huang2021abstract,
  title     = {{Abstract 1838: LBL-024, an anti-PD-L1 and 4-1BB bispecific antibody with highly differentiated binding affinity, shows anti-tumor efficacy in a mouse tumor model}},
  author    = {Huang, Xiao Bo and Sun, Jianming and Qin, Yurong and Lin, Huan and Guan, Jing Zhi and Lai, Shoupeng and Kang, Xiaoqiang and Ling, Hong},
  journal   = {Cancer Research},
  year      = {2021},
  volume    = {81},
  number    = {13_Supplement},
  pages     = {1838},
  doi       = {10.1158/1538-7445.am2021-1838},
  url       = {https://doi.org/10.1158/1538-7445.am2021-1838}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202311
202511
202611

Topic and keywords

Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers

  • bispecific antibodies
  • PD-L1 inhibitors
  • 4-1BB
  • PD-1/PD-L1 blockade
  • tumor immune checkpoint
  • NFAT signaling
  • NF-κB signaling
  • T cell activation

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Huang, X. B., Sun, J., Qin, Y., Lin, H., Guan, J. Z., Lai, S., Kang, X., & Ling, H. (2021). Abstract 1838: LBL-024, an anti-PD-L1 and 4-1BB bispecific antibody with highly differentiated binding affinity, shows anti-tumor efficacy in a mouse tumor model. Cancer Research, 81(13_Supplement), 1838. https://doi.org/10.1158/1538-7445.am2021-1838

How many times has this paper been cited?

3 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Xiao Bo Huang, Jianming Sun, Yurong Qin, Huan Lin, Jing Zhi Guan, Shoupeng Lai, Xiaoqiang Kang, Hong Ling.

What is the DOI of this paper?

10.1158/1538-7445.am2021-1838, permanently at https://doi.org/10.1158/1538-7445.am2021-1838. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.